Great West Life Assurance CO Vertex Pharmaceuticals Inc Transaction History
Great West Life Assurance CO
- $49.6 Billion
- Q1 2024
A detailed history of Great West Life Assurance CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 270,222 shares of VRTX stock, worth $128 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
270,222
Previous 278,549
2.99%
Holding current value
$128 Million
Previous $113 Million
0.27%
% of portfolio
0.23%
Previous 0.25%
Shares
28 transactions
Others Institutions Holding VRTX
# of Institutions
1,625Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.1 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$10.8 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.7 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.37 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $122B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...